The Ensign Group Reports 17.3% Revenue Growth to $1.44 Billion in Latest Quarter

The Ensign Group, Inc. reported significant financial growth in its latest quarterly results, with total revenue for the three months ended June 30, 2026, reaching $1.44 billion, a 17.3% increase from $1.23 billion in the same period last year. The company's net income attributable to shareholders also rose to $99.7 million, or $1.68 per diluted share, compared to $84.4 million, or $1.44 per diluted share, in the prior year. For the six months ended June 30, 2026, total revenue increased to $2.83 billion, up from $2.40 billion, while net income attributable to the Ensign Group was $199.4 million, compared to $164.7 million in the previous year.

The company experienced notable operational changes, including the addition of 21 stand-alone skilled nursing operations and two campus operations across four states during the first half of 2026, which contributed to an increase of 2,724 operational skilled nursing beds. This expansion reflects Ensign's strategy to enhance its market presence, particularly in Texas, which has become its largest market with 105 skilled nursing and senior living operations. The company also reported a 2.7% increase in occupancy rates for its Same Facilities, reaching 84.1%, and a 2.3% increase for Transitioning Facilities, reaching 84.7%.

In terms of financial metrics, the cost of services increased to $1.31 billion for the quarter, up from $1.12 billion a year earlier, primarily due to higher patient volumes and operational growth. However, the cost of services as a percentage of revenue decreased slightly to 78.7%, reflecting improved operational efficiencies. General and administrative expenses also rose by 24.3% to $85.9 million, driven by costs associated with system implementations and other operational needs.

Looking ahead, Ensign Group's management expressed confidence in its growth trajectory, emphasizing the importance of its operational fundamentals and the ability to integrate newly acquired facilities effectively. The company anticipates continued revenue growth driven by its expansion strategy and improved patient care services. Additionally, the company has authorized a stock repurchase program of up to $100 million, reflecting its commitment to returning value to shareholders while maintaining a strong operational focus.